Healthcare Infection Control Practices Advisory Committee, 3307-3308 [E6-615]
Download as PDF
<![CDATA[
3307
Federal Register / Vol. 71, No. 13 / Friday, January 20, 2006 / Notices
academic, and private research and
commercial organizations in tracking
changes in trends of vital events.
Respondents for the National Vital
Statistics Report form (CDC 64.146) are
registration officials in each State and
Territory, the District of Columbia, and
New York City. In addition, 33 local
(county) officials in New Mexico who
record marriages occurring in each
county of New Mexico will use this
form. The data are routinely available in
each reporting office as a by-product of
ongoing activities. This form is designed
to collect counts of monthly occurrences
of births, deaths, infant deaths,
marriages, and divorces immediately
following the month of occurrence.
The Annual Marriage and Divorce
Occurrence Report form (CDC 64.147)
collects final annual counts of marriages
and divorces by month for the United
States and for each State. The statistical
counts requested on this form differ
from provisional estimates obtained on
the National Vital Statistics Report form
in that they represent complete and
final counts of marriages, divorces, and
annulments occurring during the
months of the prior year. These final
counts are usually available from State
or county officials about eight months
after the end of the data year. The data
are widely used by government,
academic, private research, and
commercial organizations in tracking
changes in trends of family formation
and dissolution.
Respondents for the Annual Marriage
and Divorce Occurrence Report form are
registration officials in each State, the
District of Columbia, New York City,
Guam, Puerto Rico, Virgin Islands,
Northern Marianas, and American
Samoa. The data are routinely available
in each reporting office as a by-product
of ongoing activities.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
208.
ESTIMATED ANNUALIZED BURDEN TABLE
No. of respondents
Respondents
CDC64.146: State and Territory registration officials ................................................
CDC64.146: New Mexico County marriage registrars ..............................................
CDC64.147: State/Territory/City registration officials ................................................
Dated: January 11, 2006.
Betsey S. Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–621 Filed 1–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee
wwhite on PROD1PC65 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting.
Name: Clinical Laboratory Improvement
Advisory Committee (CLIAC).
Times and Dates: 8:30 a.m.–5 p.m.,
February 8, 2006; 8:30 a.m.–3 p.m., February
9, 2006.
Place: Doubletree Hotel (Atlanta/
Buckhead), 3342 Peachtree Road NE.,
Atlanta, Georgia 30326, Telephone: (404)
231–1234.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 100 people.
Purpose: This Committee is charged with
providing scientific and technical advice and
guidance to the Secretary, Department of
Health and Human Services; the Assistant
Secretary for Health; and the Director, CDC,
regarding the need for, and the nature of,
revisions to the standards under which
VerDate Aug<31>2005
16:16 Jan 19, 2006
Jkt 208001
58
33
58
clinical laboratories are regulated; the impact
on medical and laboratory practice of
proposed revisions to the standards; and the
modification of the standards to
accommodate technological advances.
Matters To Be Discussed: The agenda will
include updates from the Food and Drug
Administration, the Centers for Medicare &
Medicaid Services, and CDC; reports on
national cytology proficiency testing status
and Coordinating Council on the Clinical
Laboratory Workforce activities addressing
laboratory personnel shortages; and the role
of the public health laboratory, including
scope of services, customers, connectivity,
and preparedness.
Agenda items are subject to change as
priorities dictate.
Providing Oral or Written Comments: It is
the policy of CLIAC to accept written public
comments and provide a brief period for oral
public comments whenever possible. Oral
Comments: In general, each individual or
group requesting to make an oral
presentation will be limited to a total time of
five minutes (unless otherwise indicated).
Speakers must also submit their comments in
writing for inclusion in the meeting’s
Summary Report. To assure adequate time is
scheduled for public comments, individuals
or groups planning to make an oral
presentation should, when possible, notify
the contact person below at least one week
prior to the meeting date. Written Comments:
For individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, the
comments should be received at least one
week prior to the meeting date so that the
comments may be made available to the
Committee for their consideration and public
distribution. Written comments, one hard
copy with original signature, should be
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
No. of responses
per respondent
Average burden
per response
(in hours)
12
12
1
12/60
6/60
30/60
provided to the contact person below.
Written comments will be included in the
meeting(s Summary Report.
Contact Person for Additional Information:
Devery Howerton, Acting Chief, Laboratory
Practice Standards Branch, Division Public
Health Partnerships—Laboratory Systems,
National Center for Health Marketing,
Coordinating Center for Health Information
and Service, CDC, 4770 Buford Highway NE.,
Mailstop G–23, Atlanta, Georgia 30341–3717;
telephone (770) 488–8155; fax (770) 488–
8279; or via e-mail at DHowerton@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: January 10, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 06–518 Filed 1–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
E:\FR\FM\20JAN1.SGM
20JAN1
3308
Federal Register / Vol. 71, No. 13 / Friday, January 20, 2006 / Notices
Control and Prevention (CDC)
announces the following meeting.
Name: Healthcare Infection Control
Practices Advisory Committee (HICPAC).
Times and Dates: 8:30 a.m.–5 p.m.,
February 9, 2006. 8:30 a.m.–4 p.m., February
10, 2006.
Place: CDC Roybal Campus, Bldg 19,
Auditorium B3, 1600 Clifton Road, Atlanta,
Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Committee is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services; the Assistant Secretary for Health;
the Director, CDC; and the Director, National
Center for Infectious Diseases (NCID)
regarding (1) the practice of hospital
infection control; (2) strategies for
surveillance, prevention, and control of
infections (e.g., nosocomial infections),
antimicrobial resistance, and related events
in settings where healthcare is provided; and
(3) periodic updating of guidelines and other
policy statements regarding prevention of
healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: Agenda items
will include informatics and healthcareassociated infections, updates on public
reporting, updates on pandemic flu, updates
on antimicrobial resistance, and updates on
CDC activities of interest to the committee.
Agenda items are subject to change as
priorities dictate.
Contact Person For More Information:
Harriette Lynch, Committee Management
Specialist, HICPAC, Division of Healthcare
Quality Promotion, NCID, CDC, l600 Clifton
Road, NE, M/S A–07, Atlanta, Georgia 30333,
telephone (404)639–4035.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: January 12, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–615 Filed 1–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
wwhite on PROD1PC65 with NOTICES
[Document Identifier: CMS 10171, CMS–
250–254, and CMS–R–305]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency: Centers for Medicare &
Medicaid Services.
VerDate Aug<31>2005
16:16 Jan 19, 2006
Jkt 208001
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Coordination of
Benefits between Part D Plans and Other
Prescription Coverage Providers; Form
Number: CMS 10171 (OMB#: 0938–
0978); Use: Section 1860D–23 and
1860D–24 of the Social Security Act
requires the Secretary to establish
requirements for prescription drug plans
to ensure the effective coordination
between Part D plans, State
pharmaceutical assistance programs and
other payers. The requirements must
relate to the following elements: (1)
enrollment file sharing; (2) claims
processing and payment; (3) claims
reconciliation reports; (4) application of
the protections against high out-ofpocket expenditures by tracking True
out-of-pocket (TrOOP) expenditures;
and (5) other processes that the
Secretary determines. This information
will be used by Part D plans, other
health insurers or payers, pharmacies
and CMS to coordinate prescription
drug benefits provided to the Medicare
beneficiary.; Frequency: Reporting—
Monthly; Affected Public: Business or
other for-profit, Federal, State, Local
and or Tribal Government; Number of
Respondents: 56,320; Total Annual
Responses: 2,153,767,270; Total Annual
Hours: 1,017,914.
2. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Medicare
Secondary Payer Information Collection
and Supporting Regulations in 42 CFR
411.25, 489.2, and 489.20; Form
Number: CMS 250–254 (OMB#: 0938–
0214); Use: Medicare Secondary Payer
Information (MSP) is essentially the
same concept known in the private
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
insurance industry as coordination of
benefits, and refers to those situations
where Medicare does not have primary
responsibility for paying the medical
expenses of a Medicare beneficiary.
Medicare Fiscal Intermediaries, Carriers,
and now Part D plans, need information
about primary payers in order to
perform various tasks to detect and
process MSP cases and make recoveries.
MSP information is collected at various
times and from numerous parties during
a beneficiary’s membership in the
Medicare Program. Collecting MSP
information in a timely manner means
that claims are processed correctly the
first time, decreasing the costs
associated with adjusting claims and
recovering mistaken payments.;
Frequency: Reporting—On Occasion;
Affected Public: Individuals or
Households, Business or other for-profit,
Not-for-profit institutions; Number of
Respondents: 134,553,682; Total
Annual Responses: 134,553,682; Total
Annual Hours: 1,611,303.
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: External Quality
Review for Medicaid Managed Care
Organizations (MCOs); Form Number:
CMS–R–305 (OMB#: 0938–0786); Use:
The results of Medicare reviews,
Medicare accreditation surveys, and
Medicaid external quality reviews will
be used by States in assessing the
quality of care provided to Medicaid
beneficiaries provided by MCOs and to
provide information on the quality of
the care provided to the general public
upon request; Frequency: Annually;
Affected Public: Business or other forprofit, State, Local and or Tribal
Government; Number of Respondents:
542; Total Annual Responses: 14,266;
Total Annual Hours: 648,877.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
regulations/pra/, or E-mail your request,
including your address, phone number,
OMB number, and CMS document
identifier, to Paperwork@cms.hhs.gov,
or call the Reports Clearance Office on
(410) 786–1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received at the address below, no
later than 5 p.m. on March 21, 2006.
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development—C, Attention:
Bonnie L Harkless, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
E:\FR\FM\20JAN1.SGM
20JAN1
]]>Agencies
[Federal Register Volume 71, Number 13 (Friday, January 20, 2006)]
[Notices]
[Pages 3307-3308]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-615]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease
[[Page 3308]]
Control and Prevention (CDC) announces the following meeting.
Name: Healthcare Infection Control Practices Advisory Committee
(HICPAC).
Times and Dates: 8:30 a.m.-5 p.m., February 9, 2006. 8:30 a.m.-4
p.m., February 10, 2006.
Place: CDC Roybal Campus, Bldg 19, Auditorium B3, 1600 Clifton
Road, Atlanta, Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, Department of Health and Human Services;
the Assistant Secretary for Health; the Director, CDC; and the
Director, National Center for Infectious Diseases (NCID) regarding
(1) the practice of hospital infection control; (2) strategies for
surveillance, prevention, and control of infections (e.g.,
nosocomial infections), antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating
of guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters To Be Discussed: Agenda items will include informatics
and healthcare-associated infections, updates on public reporting,
updates on pandemic flu, updates on antimicrobial resistance, and
updates on CDC activities of interest to the committee.
Agenda items are subject to change as priorities dictate.
Contact Person For More Information: Harriette Lynch, Committee
Management Specialist, HICPAC, Division of Healthcare Quality
Promotion, NCID, CDC, l600 Clifton Road, NE, M/S A-07, Atlanta,
Georgia 30333, telephone (404)639-4035.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: January 12, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E6-615 Filed 1-19-06; 8:45 am]
BILLING CODE 4163-18-P
